AIM
ATRS

Alambic Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History

Alambic Investment Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,769
Closed -$45K – 58
2020
Q3 		$45K Sell
16,769
-28,800
-63% -$79.7K 0.49% 57
2020
Q2 		$125K Sell
45,569
-500
-1% -$1.4K 0.31% 119
2020
Q1 		$109K Sell
46,069
-72,031
-61% -$245K 0.26% 127
2019
Q4 		$555K Buy
+118,100
New +$483K 0.46% 77
2019
Q1 		– Sell
-33,300
Closed -$91K – 412
2018
Q4 		$91K Buy
+33,300
New +$110K 0.04% 280

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Alambic Investment Management's ATRS Position: Q4 2020 in Review

Alambic Investment Management sold out of Antares Pharma, Inc. (ATRS) in Q4 2020, closing a stake of 16,769 shares — an estimated $45K sold.

Alambic Investment Management first reported a position in ATRS in Q4 2018 and held it in 5 quarters. The position peaked at $555K in Q4 2019. 174 funds tracked by Wall St. Rank hold ATRS as of Q4 2020.

  • Alambic Investment Management reported no remaining Antares Pharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Alambic Investment Management sold 16,769 Antares Pharma, Inc. shares in Q4 2020, an estimated $45K.
  • Alambic Investment Management first reported a position in Antares Pharma, Inc. in Q4 2018 and held it in 5 quarters.
  • Alambic Investment Management's Antares Pharma, Inc. position peaked at $555K in Q4 2019.
  • 174 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2020.

Based on Alambic Investment Management's 13F filing for Q4 2020.